Pure Bioscience Financials
| PURE Stock | USD 0.04 0.0001 0.25% |
With this module, you can analyze Pure financials for your investing period. You should be able to track the changes in Pure Bioscience individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
Pure |
The data published in Pure Bioscience's official financial statements typically reflect Pure Bioscience's business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving Pure Bioscience's quantitative information. For example, before you start analyzing numbers published by Pure accountants, it's essential to understand Pure Bioscience's liquidity, profitability, and earnings quality within the context of the Household Products space in which it operates.
Please note, the presentation of Pure Bioscience's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Pure Bioscience's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Pure Bioscience's management manipulating its earnings.
Pure Bioscience Stock Summary
Pure Bioscience competes with Exceed World, Indofood Agri, and CCA Industries. PURE Bioscience, Inc. develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. PURE Bioscience, Inc. was incorporated in 1992 and is headquartered in Rancho Cucamonga, California. PURE BIOSCIENCE operates under Household Personal Products classification in the United States and is traded on OTC Exchange. It employs 10 people.| Instrument | USA OTC Stock View All |
| Exchange | OTCQB Exchange |
| ISIN | US74621T2096 |
| Business Address | 9669 Hermosa Avenue, |
| Sector | Household Products |
| Industry | Consumer Staples |
| Benchmark | Dow Jones Industrial |
| Website | www.purebio.com |
| Phone | 619 596 8600 |
| Currency | USD - US Dollar |
Pure Bioscience Key Financial Ratios
There are many critical financial ratios that Pure Bioscience's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Pure Bioscience reports annually and quarterly.Pure Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Pure Bioscience's current stock value. Our valuation model uses many indicators to compare Pure Bioscience value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Pure Bioscience competition to find correlations between indicators driving Pure Bioscience's intrinsic value. More Info.Pure Bioscience is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Pure Bioscience's earnings, one of the primary drivers of an investment's value.Pure Bioscience Systematic Risk
Pure Bioscience's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Pure Bioscience volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was three with a total number of output elements of fifty-eight. The Beta measures systematic risk based on how returns on Pure Bioscience correlated with the market. If Beta is less than 0 Pure Bioscience generally moves in the opposite direction as compared to the market. If Pure Bioscience Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Pure Bioscience is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Pure Bioscience is generally in the same direction as the market. If Beta > 1 Pure Bioscience moves generally in the same direction as, but more than the movement of the benchmark.
Pure Bioscience January 6, 2026 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Pure Bioscience help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Pure Bioscience. We use our internally-developed statistical techniques to arrive at the intrinsic value of Pure Bioscience based on widely used predictive technical indicators. In general, we focus on analyzing Pure OTC Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Pure Bioscience's daily price indicators and compare them against related drivers.
| Information Ratio | (0.12) | |||
| Maximum Drawdown | 40.0 | |||
| Value At Risk | (16.67) | |||
| Potential Upside | 14.29 |
Complementary Tools for Pure OTC Stock analysis
When running Pure Bioscience's price analysis, check to measure Pure Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pure Bioscience is operating at the current time. Most of Pure Bioscience's value examination focuses on studying past and present price action to predict the probability of Pure Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pure Bioscience's price. Additionally, you may evaluate how the addition of Pure Bioscience to your portfolios can decrease your overall portfolio volatility.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |